sabra health care reit inc. - SBRA
SBRA
Close Chg Chg %
20.79 0.13 0.63%
Open Market
20.92
+0.13 (0.63%)
Volume: 640.95K
Last Updated:
Sep 10, 2026, 10:55 AM EDT
Company Overview: sabra health care reit inc. - SBRA
SBRA Key Data
| Open $20.79 | Day Range 20.79 - 21.11 |
| 52 Week Range 17.17 - 22.77 | Market Cap $5.31B |
| Shares Outstanding 255.46M | Public Float 250.59M |
| Beta 0.64 | Rev. Per Employee N/A |
| P/E Ratio 79.89 | EPS $0.27 |
| Yield 576.65% | Dividend $0.30 |
| EX-DIVIDEND DATE Aug 14, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 2.14M |
SBRA Performance
| 1 Week | 0.05% | ||
| 1 Month | -1.19% | ||
| 3 Months | 11.00% | ||
| 1 Year | 9.13% | ||
| 5 Years | 27.08% |
SBRA Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
17
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 22.786 | |
| Number of Ratings | 17 | Current Quarters Estimate | 0.169 | |
| FY Report Date | 09 / 2026 | Current Year's Estimate | 0.47 | |
| Last Quarter’s Earnings | -0.10 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.64 | Next Fiscal Year Estimate | 0.766 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 9 | 9 | 9 | 9 |
| Mean Estimate | 0.17 | 0.18 | 0.47 | 0.77 |
| High Estimates | 0.19 | 0.21 | 0.75 | 0.85 |
| Low Estimate | 0.15 | 0.16 | 0.38 | 0.71 |
| Coefficient of Variance | 8.75 | 8.56 | 31.21 | 7.38 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 7 | 6 | 5 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 10 | 10 | 8 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 1 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Sabra Health Care Reit Inc. - SBRA
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Sabra Health Care Reit Inc. - SBRA
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 4, 2026 | Michael J. Foster Director | 74,719 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 4, 2026 | Richard K. Matros Chair, CEO and President; Director | 928,398 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 4, 2026 | Craig A. Barbarosh Director | 54,199 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 4, 2026 | Jeffrey A. Malehorn Director | 107,219 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 4, 2026 | Michael Costa Executive VP, CFO & Treasurer | 461,521 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 4, 2026 | Ann Yee-Kono Director | 59,059 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 4, 2026 | Jessica Flores Executive VP & CAO | 86,940 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 4, 2026 | Lynne S. Katzmann Director | 76,994 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 4, 2026 | Darrin Smith Executive VP, CIO & Secretary | 115,923 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 4, 2026 | Katie Cusack Director | 72,929 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Dec 3, 2025 | Talya Nevo-Hacohen Executive VP, CIO & Treasurer | 340,355 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |